Development

INSIGHTS ON DRUG DEVELOPMENT

Formulation Development Of Enterically Protected Spray Dried Dispersions
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
Data-Driven Strategies To De-Risk OSD Development
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
Increase Throughput For Intact Mass Confirmation And Impurity Screening
Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.

AustinPx Site Tour
5/2/2025

Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.
Strategies For The Development Of Safe And Effective Pediatric Formulations
5/12/2025

Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
Easy Automation For Cell-Based Assays
10/10/2025

Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
Sustainability In On-Body Delivery System Platforms
7/2/2026

Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.
Why Emerging Drug Developers Can't Afford To Delay Analytical Development
5/21/2026

Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

Mass Spectrometry Software For Spectral Interpretation And Characterization
One MS Software for All Your Mass Spectral Data Analysis and Management

ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
Simplify Your Single Cell Workflow Like Never Before

Discover an automated, precise, and gentle system that simplifies single-cell workflows with fast dispensing, broad cell compatibility, and intuitive software.
Predict And Assign Fragment Ions

Model MS fragmentation pathways and align predictions with experimental data to assign fragment ions faster. Streamline spectral interpretation and confirm compound identities with greater confidence.
Early Development: Accelerating Molecules Through To Proof-Of-Concept

Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
Small Molecule Discovery Network And Capabilities

Our collaborative approach, proven track record, and deep technical expertise enable us to efficiently advance promising candidates, reduce development risk, and help transform innovative ideas into successful therapeutic realities.